UK: CMA cancels its merger investigation into Experian’s purchase of ClearScore
The Competition and Markets Authority (CMA) has cancelled its merger investigation into Experian’s anticipated purchase of ClearScore.
Experian and ClearScore provide credit-score checking and financial product comparison services in the UK. These services allow people to understand their finances and choose loans and credit cards online.
In November 2018, the CMA published provisional findings as part of its in-depth, Phase 2, merger inquiry. These set out concerns that the merger of 2 of the largest credit-score checking firms in the UK could result in less intense competition in the sector.
The CMA provisionally found that the merger could stifle product development, by substantially reducing the pressure to continue to develop innovative offers and to make other improvements in services, and so negatively impact consumers.
Experian and ClearScore decided not to continue with the deal.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas